Difference between revisions of "Team:Lethbridge"
Keithaiken (Talk | contribs) |
Keithaiken (Talk | contribs) |
||
| Line 34: | Line 34: | ||
<p class="f18">Software framework to begin database of PNCs </p> | <p class="f18">Software framework to begin database of PNCs </p> | ||
</div> | </div> | ||
| − | <center><img src="https://static.igem.org/mediawiki/2018/6/60/T--Lethbridge--computer_vincent.png"></center> | + | <center><img src="https://static.igem.org/mediawiki/2018/6/60/T--Lethbridge--computer_vincent.png" width: 60%></center> |
</div> | </div> | ||
| Line 41: | Line 41: | ||
<h1>Risk Assessment Rubric</h1> | <h1>Risk Assessment Rubric</h1> | ||
| − | <img src="https://static.igem.org/mediawiki/2018/2/20/T--Lethbridge--law_vincent.png"> | + | <div class="imageText-Wrapper"> |
| − | + | <div class="imageText-Image"> | |
| + | <center><img src="https://static.igem.org/mediawiki/2018/2/20/T--Lethbridge--law_vincent.png"></center> | ||
| + | </div> | ||
| + | <div class="imageText-Text"> | ||
<p class="f18">Developed for our toolkit with advice from PHAC (Public Health Agency of Canada) and members of ELBI (Emerging Leaders in Biosecurity Initiative)</p> | <p class="f18">Developed for our toolkit with advice from PHAC (Public Health Agency of Canada) and members of ELBI (Emerging Leaders in Biosecurity Initiative)</p> | ||
| + | </div> | ||
| + | </div> | ||
<br> | <br> | ||
<h1>Cell-free Synthesis Components</h1> | <h1>Cell-free Synthesis Components</h1> | ||
| − | + | <div class="oneText-Wrapper"> | |
| + | <div class="oneText-Text"> | ||
| + | <ul> | ||
<li class="f18"> 15 parts improved from our N<i>ex</i>t <i>vivo</i> project. </li> | <li class="f18"> 15 parts improved from our N<i>ex</i>t <i>vivo</i> project. </li> | ||
<li class="f18"> Our goal with these parts was to continue standardizing, improving and simplifying our protocols.</li> | <li class="f18"> Our goal with these parts was to continue standardizing, improving and simplifying our protocols.</li> | ||
<li class="f18"> Beginning design of Cell Free PNC Synthesis.</li> | <li class="f18"> Beginning design of Cell Free PNC Synthesis.</li> | ||
| + | </ul> | ||
| + | </div> | ||
| + | </div> | ||
| + | <div class="oneImage-Wrapper"> | ||
| + | <div class="oneImage-Image"> | ||
<img src="https://static.igem.org/mediawiki/2018/6/6e/T--Lethbridge--next_vivo.png"> | <img src="https://static.igem.org/mediawiki/2018/6/6e/T--Lethbridge--next_vivo.png"> | ||
| + | </div> | ||
| + | </div> | ||
| − | < | + | </div> <!-- closing out 'content'--> |
| − | + | ||
| − | + | ||
</body> | </body> | ||
</html> | </html> | ||
Revision as of 00:37, 18 October 2018
Protein Nanocompartments
Modifiable surfaces for specific targeting and suitability of packaging for a variety of cargo types
Software
Software framework to begin database of PNCs
Risk Assessment Rubric
Developed for our toolkit with advice from PHAC (Public Health Agency of Canada) and members of ELBI (Emerging Leaders in Biosecurity Initiative)
Cell-free Synthesis Components
- 15 parts improved from our Next vivo project.
- Our goal with these parts was to continue standardizing, improving and simplifying our protocols.
- Beginning design of Cell Free PNC Synthesis.
